Atria Wealth Solutions Inc. Decreases Stock Holdings in Tilray Brands, Inc. $TLRY

Atria Wealth Solutions Inc. reduced its position in shares of Tilray Brands, Inc. (NASDAQ:TLRY) by 29.3% in the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 59,753 shares of the company’s stock after selling 24,763 shares during the period. Atria Wealth Solutions Inc.’s holdings in Tilray Brands were worth $39,000 at the end of the most recent reporting period.

Other institutional investors have also modified their holdings of the company. Lido Advisors LLC purchased a new stake in shares of Tilray Brands during the 4th quarter worth $28,000. Cerity Partners LLC purchased a new stake in shares of Tilray Brands during the 1st quarter worth $31,000. Capital Management Associates Inc raised its stake in Tilray Brands by 100.0% during the 1st quarter. Capital Management Associates Inc now owns 50,760 shares of the company’s stock worth $33,000 after acquiring an additional 25,380 shares in the last quarter. NewEdge Advisors LLC raised its stake in Tilray Brands by 92.1% during the 4th quarter. NewEdge Advisors LLC now owns 27,406 shares of the company’s stock worth $36,000 after acquiring an additional 13,136 shares in the last quarter. Finally, Zacks Investment Management acquired a new stake in Tilray Brands during the 4th quarter worth $41,000. 9.35% of the stock is owned by hedge funds and other institutional investors.

Insider Activity at Tilray Brands

In other Tilray Brands news, CEO Irwin D. Simon bought 165,000 shares of Tilray Brands stock in a transaction dated Wednesday, July 30th. The stock was acquired at an average cost of $0.61 per share, with a total value of $100,650.00. Following the completion of the acquisition, the chief executive officer owned 3,941,633 shares of the company’s stock, valued at approximately $2,404,396.13. This represents a 4.37% increase in their ownership of the stock. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Insiders own 0.60% of the company’s stock.

Tilray Brands Price Performance

Shares of NASDAQ:TLRY opened at $1.03 on Monday. The company’s fifty day moving average price is $0.59 and its 200 day moving average price is $0.61. Tilray Brands, Inc. has a 12 month low of $0.35 and a 12 month high of $1.97. The company has a debt-to-equity ratio of 0.20, a current ratio of 2.46 and a quick ratio of 1.49. The firm has a market capitalization of $1.13 billion, a P/E ratio of -0.45 and a beta of 1.85.

Tilray Brands (NASDAQ:TLRY) last announced its earnings results on Monday, July 28th. The company reported $0.02 EPS for the quarter, beating analysts’ consensus estimates of ($0.03) by $0.05. Tilray Brands had a negative net margin of 265.69% and a negative return on equity of 6.83%. The business had revenue of $224.54 million during the quarter, compared to analysts’ expectations of $250.41 million. As a group, sell-side analysts predict that Tilray Brands, Inc. will post -0.2 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In

Several brokerages recently commented on TLRY. Zelman & Associates reiterated a “neutral” rating on shares of Tilray Brands in a research note on Tuesday, July 29th. Wall Street Zen lowered shares of Tilray Brands to a “strong sell” rating in a research note on Saturday, July 5th. One investment analyst has rated the stock with a sell rating, four have assigned a hold rating and one has given a buy rating to the company’s stock. Based on data from MarketBeat, the company has a consensus rating of “Hold” and an average target price of $1.92.

Tilray Brands Company Profile

Tilray, Inc engages in the research, cultivation, processing, and distribution of medical cannabis. The company offers its products in Argentina, Australia, Canada, Chile, Croatia, Cyprus, the Czech Republic, Germany, New Zealand, and South Africa. Tilray, Inc is headquartered in Canada.